SELL and psoriasis: Another 2025 study comparing erythrodermic CTCL to chronic idiopathic erythroderma, atopic dermatitis, psoriasis, and healthy controls found that erythrodermic CTCL had expanded CD4+ malignant cells with a CCR7+SELL+ central memory phenotype [35].